Literature DB >> 8258152

Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responses.

A W Hügin1, C Flexner, B Moss.   

Abstract

Recombinant vaccinia viruses that express the human or mouse IL-2 gene are rapidly eliminated from immunoincompetent nude mice whereas control viruses cause lethal infections. To understand the role that virus-encoded IL-2 plays in attenuation, we investigated the mechanism of virus elimination from nude mice. Survival correlated with accelerated clearance of the virus. Treatment of infected mice with antibodies to eliminate NK cells or to neutralize interferon-gamma suggested that both are involved in the elimination of IL-2-producing virus. However, lytic activity of NK cells was not necessary as shown by studies with beige mice. Coinfection with IL-2-expressing and control virus resulted in lethal infection of nude mice, indicating the absence of significant systemic immunity. Focally acting immunopotentiating and chemotactic activities of virus-encoded IL-2 and host-derived interferon-gamma seem to confer protection in this novel approach to virus attenuation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258152     DOI: 10.1006/cimm.1993.1307

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.

Authors:  SangKon Oh; Jay A Berzofsky; Donald S Burke; Thomas A Waldmann; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.

Authors:  Rafal J Zielinski; Jeremy V Smedley; Pin-Yu Perera; Peter M Silvera; Thomas A Waldmann; Jacek Capala; Liyanage P Perera
Journal:  Vaccine       Date:  2010-08-20       Impact factor: 3.641

3.  Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.

Authors:  L P Perera; C K Goldman; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

4.  Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines.

Authors:  A Bukreyev; S S Whitehead; C Prussin; B R Murphy; P L Collins
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells.

Authors:  Joseph F Grosso; Monica V Goldberg; Derese Getnet; Tullia C Bruno; Hung-Rong Yen; Kristin J Pyle; Edward Hipkiss; Dario A A Vignali; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

6.  IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis.

Authors:  Sangkon Oh; Liyanage P Perera; Masaki Terabe; Ling Ni; Thomas A Waldmann; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

7.  Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing.

Authors:  Tomoyoshi Inoue; Thomas Byrne; Mitsuko Inoue; Madeline E Tait; Patrick Wall; Annabel Wang; Michael R Dermyer; Hanane Laklai; Joseph J Binder; Clare Lees; Robert Hollingsworth; Liliana Maruri-Avidal; David H Kirn; Donald M McDonald
Journal:  Mol Cancer Ther       Date:  2021-05-27       Impact factor: 6.261

8.  Expression of chicken interleukin-2 by a highly virulent strain of Newcastle disease virus leads to decreased systemic viral load but does not significantly affect mortality in chickens.

Authors:  Leonardo Susta; Diego G Diel; Sean Courtney; Stivalis Cardenas-Garcia; Roy S Sundick; Patti J Miller; Corrie C Brown; Claudio L Afonso
Journal:  Virol J       Date:  2015-08-08       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.